Cancer Prevention   

Questions discussed in this category



Would you restart hormonal therapy in a patient with a new diagnosis of LCIS 2 years after they have completed 5 yrs of AI for stage 1A IDC in the oth...

Genes such as ATM, CHEK2, PALB2, RAD51C/D, BRIP1 seem to show some potential increased risk of ovarian cancer. Should these patients under prophylacti...

In a scenario where patient's other clinical/familial risk does not sufficiently qualify them? See JCO OGR 8/2021 by @Mark E. Robson discussing manag...

Is there a difference among all the commercial genetic testing labs? Is there anything beyond CLIA- and CAP-certification that we should look for...


Papers discussed in this category


NPJ breast cancer, 2016

Journal of the National Cancer Institute, 1998-09-16

Lancet (London, England), 2002-09-14

Journal of the National Cancer Institute, 2007-05-02

Lancet,

Annals of surgical oncology, 2010-10

Br J Cancer, 2014 Jun 10

Cochrane Database Syst Rev, 2010 Nov 10

J. Clin. Oncol., 2021 Aug 10

Expert review of anticancer therapy, 2009-01

Annals of the New York Academy of Sciences, 2001-12

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2013-01

AJR Am J Roentgenol, 2021 May 12

Cancer Prev Res (Phila), 2013 Aug 20

Breast Cancer Res Treat, 2011 Oct 22